• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白修饰:原因还是结果?

Histone modification: cause or cog?

机构信息

Basic Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA.

出版信息

Trends Genet. 2011 Oct;27(10):389-96. doi: 10.1016/j.tig.2011.06.006. Epub 2011 Jul 20.

DOI:10.1016/j.tig.2011.06.006
PMID:21764166
Abstract

Histone modifications are key components of chromatin packaging but whether they constitute a 'code' has been contested. We believe that the central issue is causality: are histone modifications responsible for differences between chromatin states, or are differences in modifications mostly consequences of dynamic processes, such as transcription and nucleosome remodeling? We find that inferences of causality are often based on correlation and that patterns of some key histone modifications are more easily explained as consequences of nucleosome disruption in the presence of histone modifying enzymes. We suggest that the 35-year-old DNA accessibility paradigm provides a mechanistically sound basis for understanding the role of nucleosomes in gene regulation and epigenetic inheritance. Based on this view, histone modifications and variants contribute to diversification of a chromatin landscape shaped by dynamic processes that are driven primarily by transcription and nucleosome remodeling.

摘要

组蛋白修饰是染色质包装的关键组成部分,但它们是否构成“密码”一直存在争议。我们认为核心问题是因果关系:组蛋白修饰是否导致了染色质状态的差异,还是修饰的差异主要是转录和核小体重塑等动态过程的结果?我们发现,因果关系的推断往往基于相关性,而且一些关键组蛋白修饰的模式更容易被解释为组蛋白修饰酶存在时核小体破坏的结果。我们认为,35 年前提出的 DNA 可及性范例为理解核小体在基因调控和表观遗传遗传中的作用提供了一个合理的机制基础。基于这一观点,组蛋白修饰和变体有助于由主要由转录和核小体重塑驱动的动态过程所塑造的染色质景观的多样化。

相似文献

1
Histone modification: cause or cog?组蛋白修饰:原因还是结果?
Trends Genet. 2011 Oct;27(10):389-96. doi: 10.1016/j.tig.2011.06.006. Epub 2011 Jul 20.
2
Interplay between different epigenetic modifications and mechanisms.不同表观遗传修饰和机制之间的相互作用。
Adv Genet. 2010;70:101-41. doi: 10.1016/B978-0-12-380866-0.60005-8.
3
Epigenetic regulators and histone modification.表观遗传调控因子与组蛋白修饰
Brief Funct Genomic Proteomic. 2006 Sep;5(3):222-7. doi: 10.1093/bfgp/ell030. Epub 2006 Sep 2.
4
The nucleosome: a little variation goes a long way.核小体:微小的变异影响深远。
Biochem Cell Biol. 2006 Aug;84(4):505-17. doi: 10.1139/o06-085.
5
Nucleosome destabilization in the epigenetic regulation of gene expression.基因表达表观遗传调控中的核小体去稳定化
Nat Rev Genet. 2008 Jan;9(1):15-26. doi: 10.1038/nrg2206.
6
Chromatin response to DNA double-strand break damage.染色质对 DNA 双链断裂损伤的响应。
Epigenomics. 2011 Jun;3(3):307-21. doi: 10.2217/epi.11.14.
7
Histone acetylation and methylation: combinatorial players for transcriptional regulation.组蛋白乙酰化与甲基化:转录调控的组合参与者
Subcell Biochem. 2007;41:351-69.
8
How does the histone code work?组蛋白密码是如何起作用的?
Biochem Cell Biol. 2005 Aug;83(4):468-76. doi: 10.1139/o05-137.
9
Is histone loss a common feature of DNA metabolism regulation?组蛋白缺失是DNA代谢调控的一个常见特征吗?
Biochem Cell Biol. 2006 Aug;84(4):450-62. doi: 10.1139/o06-070.
10
Epigenetic information in chromatin and cancer.染色质和癌症中的表观遗传学信息。
Eur J Cancer. 2009 Sep;45 Suppl 1:442-4. doi: 10.1016/S0959-8049(09)70082-6.

引用本文的文献

1
Aere perennius: how chromatin fidelity is maintained and lost in disease.经久不衰:疾病中染色质保真度是如何维持和丧失的
NAR Mol Med. 2025 Jul 22;2(3):ugaf026. doi: 10.1093/narmme/ugaf026. eCollection 2025 Jul.
2
KDM4C inhibition blocks tumor growth in basal breast cancer by promoting cathepsin L-mediated histone H3 cleavage.KDM4C抑制通过促进组织蛋白酶L介导的组蛋白H3切割来阻断基底样乳腺癌的肿瘤生长。
Nat Genet. 2025 Jun 2. doi: 10.1038/s41588-025-02197-z.
3
Epigenetic Echoes: Bridging Nature, Nurture, and Healing Across Generations.
表观遗传回声:跨越世代连接天性、教养与治愈。
Int J Mol Sci. 2025 Mar 27;26(7):3075. doi: 10.3390/ijms26073075.
4
RNA polymerase II coordinates histone deacetylation at active promoters.RNA聚合酶II在活跃启动子处协调组蛋白去乙酰化作用。
Sci Adv. 2025 Feb 7;11(6):eadt3037. doi: 10.1126/sciadv.adt3037. Epub 2025 Feb 5.
5
Nucleosome repositioning in cardiac reprogramming.心脏重编程中的核小体重新定位。
PLoS One. 2025 Jan 15;20(1):e0317718. doi: 10.1371/journal.pone.0317718. eCollection 2025.
6
Chromatin-based memory as a self-stabilizing influence on cell identity.基于染色质的记忆对细胞身份的自我稳定影响。
Genome Biol. 2024 Dec 30;25(1):320. doi: 10.1186/s13059-024-03461-x.
7
Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib.病例报告:免疫治疗的显著疗效:信迪利单抗联合安罗替尼治疗化疗耐药的晚期肺肉瘤样癌患者的显著疗效。
Front Immunol. 2024 Nov 6;15:1452195. doi: 10.3389/fimmu.2024.1452195. eCollection 2024.
8
A vector system encoding histone H3 mutants facilitates manipulations of the neuronal epigenome.一种编码组蛋白 H3 突变体的载体系统可方便地对神经元表观基因组进行操作。
Sci Rep. 2024 Oct 18;14(1):24415. doi: 10.1038/s41598-024-74270-2.
9
Epigenetic therapies targeting histone lysine methylation: complex mechanisms and clinical challenges.针对组蛋白赖氨酸甲基化的表观遗传疗法:复杂的机制和临床挑战。
J Clin Invest. 2024 Oct 15;134(20):e183391. doi: 10.1172/JCI183391.
10
RNA Polymerase II coordinates histone deacetylation at active promoters.RNA聚合酶II在活跃启动子处协调组蛋白去乙酰化作用。
bioRxiv. 2024 Sep 17:2024.09.17.613553. doi: 10.1101/2024.09.17.613553.